ConductScience.org, home

Paper3948299

The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.

Harpur ES and 3 others. Cancer Chemother Pharmacol, 1986. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination. Papers, record 3948299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3948299

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2019-08-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harpur ESE S
2Langdon SPS P
3Fathalla SAS A
4Ishmael JJ

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
FormamidesMajor topic
KidneyMajor topic
LiverMajor topic
Animals
Antineoplastic Combined Chemotherapy Protocols
Blood Cell Count
Blood Urea Nitrogen
Calcium
Creatinine
Drug Evaluation, Preclinical
Female
Injections, Intraperitoneal
L-Lactate Dehydrogenase
Lethal Dose 50
Leukocyte Count
Leukopenia
Male
Mice
Rats
Rats, Inbred F344
Sarcoma, Experimental

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1276884Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/276884PubMed
31021237Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.Cancer Treat Rep1976https://conductscience.org/library/papers/1021237PubMed
4240515Reaction-rate assay of serum sorbitol dehydrogenase activity of 37 degrees C.Clin Chem1975https://conductscience.org/library/papers/240515PubMed
54018116N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.Eur J Cancer Clin Oncol1985https://conductscience.org/library/papers/4018116PubMed
66931873Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy.J Med1980https://conductscience.org/library/papers/6931873PubMed
76127169Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6127169PubMed
85350464Enzymes in rat urine. I. A metabolism cage for the complete separation of urine and faeces.Enzymologia1969https://conductscience.org/library/papers/5350464PubMed
107139607Inhibition of the growth of human colon cancer xenografts by polar solvents.Cancer Res1982https://conductscience.org/library/papers/7139607PubMed
117027859Renal and electrolyte disturbances associated with cisplatin.Ann Intern Med1981https://conductscience.org/library/papers/7027859PubMed
12638991Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man.Cancer1978https://conductscience.org/library/papers/638991PubMed
134336672[Isolation and characterization of a plasma membrane fraction from the proximal tubules of human kidney].Clin Chim Acta1972https://conductscience.org/library/papers/4336672PubMed
146987030Comparison of methods of evaluating nephrotoxicity of cis-platinum.Clin Pharmacol Ther1980https://conductscience.org/library/papers/6987030PubMed
156704151An investigation of the mechanism of hepatotoxicity of the antitumour agent N-methylformamide in mice.Biochem Pharmacol1984https://conductscience.org/library/papers/6704151PubMed
16375794Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.Ann Intern Med1979https://conductscience.org/library/papers/375794PubMed
196428895The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6428895PubMed
206325001Phase I trial of N-methylformamide.Cancer Treat Rep1984https://conductscience.org/library/papers/6325001PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
8913832Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis.Invest New Drugs1996https://conductscience.org/library/papers/8913832PubMed
3665221Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.Clin Exp Metastasis1987https://conductscience.org/library/papers/3665221PubMed
2599802Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.Invest New Drugs1989https://conductscience.org/library/papers/2599802PubMed
2328201Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.Br J Cancer1990https://conductscience.org/library/papers/2328201PubMed
2066356Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.J Cancer Res Clin Oncol1991https://conductscience.org/library/papers/2066356PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3948299

GET https://conductscience.org/api/papers/v1/3948299/authors